Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-centre randomized double blind placebo-controlled trial of Neurotec in fibromyalgia syndrome
IRCT138708061411N2Phase 3Completed
- Sponsor
- Pars Roos
- Start
- Nov 2008
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Neurotec in fibromyalgia (FM), sponsored by Pars Roos. Started Nov 2008; status: completed.
02
Drugs
Neurotec
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on IRCT138708061411N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138708061411N2.